Renal and urology Flashcards
What cancer is aniline a RF for?
bladder cancer
What is the pathogen most common associated with haemolytic uraemic syndrome?
E. coli strain O157
what are the characteristic features of haemolytic uraemic syndrome?
microangiopathic haemolytic anaemia (MAHA)
acute renal failure (AKI)
thrombocytopenia
What are the symptoms of haemolytic uraemic syndrome?
profuse diarrhoea which turns bloody 1-3 days later
abdominal pain
reduced urine output
haematuria
nausea
fever
malaise
swelling/oedema
differentials for scrotal lumps
- Scrotal skin
- Sebaceous cyst
- Melanoma
- Intra-vaginal
- Hydrocele
- Epididymal cyst
- Epididymitis
- Hernia
- Torted hydatid
- Intra-testicular
- Orchitis
- Testicular abscess
- Testicular cancer
- Lymphoma
- Other
- Sarcoma of the cord
- Lipoma of the cord
causes of visible haematuria (UROLOGY)
- Bladder cancer
- Infection
- Simple UTI
- Schistosomiasis
- TB
- Urinary tract calculi
- Prostatic bleeding
- Trauma
- Upper tract transitional cell carcinoma
- Renal cancer
- Prostate cancer
- Radiation cystitis
causes of transient or spurious non-visible haematuria
- urinary tract infection
- menstruation
- vigorous exercise (this normally settles after around 3 days)
- sexual intercourse
causes of persistent non-visible haematuria
- cancer (bladder, renal, prostate)
- stones
- benign prostatic hyperplasia
- prostatitis
- urethritis e.g. Chlamydia
- renal causes: IgA nephropathy, thin basement membrane disease
how many stages of AKI are there?
3
describe stage 1 AKI
- Creatinine ↑ > 26 micromol/L within 48 hours OR
- Creatinine risk of 50-99% of baseline within 7 days (1.5-1.99 x baseline) OR
- Urine output < 0.5 ml/kg/hour for > 6 hours
describe stage 2 AKI
- 100-199% creatinine rise from baseline within 7 days (2-2.99 x baseline) OR
- Urine output < 0.5 ml/kg/hour for > 12 hours
describe AKI stage 3
- > 200% creatinine rise from baseline within 7 days (> 3 x baseline) OR
- Creatinine rise to > 354 micromol/L with acute rise of > 26 micromol/L within 48 hours or > 50% within 7 days OR
- Urine output < 0.3 ml/kg/hr for 24 hours or anuria for 12 hours
what are the indications for dialysis?
- Indications AEIOU
- Acidosis - severe metabolic acidosis with pH < 7.2
- Electrolyte imbalance - persistent hyperkalaemia > 7mM
- Intoxication - poisoning
- Oedema - refractory pulmonary oedema
- Uraemia - encephalopathy or pericarditis
where does BPH hyperplasia occur? histological features
hyperplasia in transitional zone
increase in stromal: epithelial ratio
Ix for BPH
- bedside
- DRE
- urinalysis
- bloods
- PSA + UE&s
- imaging
- bladder scan, USS KUB if concern of hydronephrosis
- specialist
- international prostate symptoms score (IPSS)
- urodynamic studies
management of BPH
-
Conservative
- Mild disease can watch-and-wait strategy
- Bladder training - less effective if LUTS + proven outlet obstruction
- reduce caffeine, ETOH, Tx constipation
-
Medical
-
Alpha adrenoceptor antagonist
- Alpha blocker e.g doxazosin, tamsulosin
- ↓ smooth muscle tone, quick effect
-
5-alpha reductase inhibitor
- e.g. finasteride
- If prostate > 30g or PSA >1.4 ng/ml + high risk of progression
- prevents dihydrotestosterone formation → ↓ prostate volume
- longer onset
-
Dual therapy
- Moderate-severe LUTs and prostate > 30g or PSA > 1.4ng/ml
-
Alpha adrenoceptor antagonist
-
Surgical
- Indicated - severe sx, refractory
- surgical resection to reduce prostate mass
what are the surgical options for BPH?
- TURP
- Transurethral incision of prostate (TUIP) if prostate < 30g but symptomatic
- REZUM - steam vapour to shrink prostate, 30-80g prostate, IPSS > 13
- HoLEP - holmium laser enucleates prostate, useful in very large prostates
- Urolift - staples back lateral lobes of prostate, useful in young as ↓ retrograde ejaculation
- Radical prostatectomy - prostate > 80g
types of bladder cancer + most common
- Transitional cell carcinoma (urothelial carcinoma, 90%)
- Adenocarcinoma
- Squamous cell carcinoma - associated with schistosomiasis
- Sarcoma
Ix for bladder cancer
-
Bedside
- Urinalysis + MC&S
-
Bloods
- FBC, U&Es, ALP
-
Imaging
- CT urogram
- multiparametric MRI - staging, indicated before TURBT
- USS KUB - usually 1st line if non-visible haematuria
-
Specialist or scoring
- Flexible cystoscopy - diagnostic
-
Transurethral resection of a bladder tumour (diagnostic or curative, must obtain detrusor biopsy)
- NICE - white-like guided TURBT with photodynamic diagnostics
2ww rules for bladder CA
- > 45 + unexplained visible haematuria w/o UTI
- > 45 + visible haematuria that persists/recurs after UTI treatment
- > 60 + unexplained non-visible haematuria and dysuria/↑ WCC
bladder cancer management
-
non muscle invasive
- low risk - TURBT single intravesible mitomycin C
- intermediate - TURBT + 6 course intravesical mitomycin
- high risk - intravesical chemo or radical cystectomy
- f/up with cytoscopy
-
muscle invasive
- neoadjuvant cisplatin chemo
- radical cystectomy or radial radiotherapy
-
locally advanced or metastatic
- cisplatin combination chemotherapy
- pembrolizumab (if PD-L1 +ve)
NICE definition of CKD
CKD should be diagnosed if any of the following met for more than 3 months(NICE):
- Markers of renal damage are present such as:
- Urinary ACR > 3mg/ml
- Urine sediment abnormalities
- Electrolyte or tubular disorders
- Abnormality on histology
- Structural abnormality on imaging
- History of transplant
- Persistent reduction in renal function with serum eGFR < 60
give the impairment of water balance seen in CKD and Sx + signs
Fluid overload, hypervolaemia
signs and symptoms
- Pleural effusions (SOB, cough)
- Pedal or sacral oedema
- Ascites
- Reduced urine output due to poor filtration
give the impairment of electrolyte homeostasis seen in CKD and Sx + signs
Hyperkalaemia
Cardiac dysrhythmias, palpitations
what is the excretion of waste impairment of function in CKD and presentation
uraemia
Pruritis, pericarditis, encephalopathy
what is the acid-base disturbance in CKD + PC
acidosis
N+V, tiredness
what is the endocrine disturbance in CKD and PC
-
Normocytic anaemia
- Tired, SOB, pallor, headaches, LOC, chest pain, weakness, HF
-
Hypocalcaemia
- Tetany, secondary hyperparathyroidism (Brown’s tumours, adynamic bone turnover), osteomalacia/osteoporosis
- Hypertension
complications of CKD
- ESRF, AKI (acute-on-chronic)
- HTN, dyslipidaemia (e.g. secondary to nephrotic syndrome), CVD risk ↑ (renal osteodystrophy
- anaemia
- bone pain/fragility #, renal osteodystrophy (osteoporosis, necrosis + pathological #)
- Peripheral neuropathy and myopathy incl. paraesthesia, sleep disturbance, restless leg syndrome
- Malnutrition (ESRF) - poor intake + hypoalbuminaemia